Search Tag: Masimo

ICU Management

Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® & Connectivity Hub

2017 20 Mar

Masimo Rad-97™ Pulse CO-Oximeter® and Connectivity Hub with Noninvasive Blood Pressure Masimo (NASDAQ: MASI) has announced the CE marking of noninvasive blood pressure (NIBP) measurements for the Rad-97™ Pulse CO-Oximeter® and connectivity hub. Rad-97 offers Measure-through Motion and Low Perfusion™ SET® pulse oximetry and upgradeable rainbow® noninvasive... Read more

ICU Management

New Study Evaluates the Utility of Masimo SpHb® Monitoring During Liver Transplantation

2017 19 Mar

Masimo (NASDAQ: MASI) has announced the publication of a recent study conducted on adult patients undergoing liver transplantation (LT), in which researchers assessed the accuracy and trending ability of noninvasive Masimo SpHb® (total hemoglobin) measurement, as compared to conventional laboratory hemoglobin (HbL) measurements. The researchers found... Read more

ICU Management

Masimo Announces Availability of the RD SedLine® Adult EEG Sensor

2017 07 Mar

Masimo (NASDAQ: MASI) has announced availability of the RD SedLine® EEG sensor, for use with Masimo SedLine Brain Function Monitoring and compatible with simultaneous use of Masimo O3™ Regional Oximetry. SedLine and O3 provide simultaneous monitoring on the Masimo Root® monitoring platform, helping to give clinicians more information about the brain.The... Read more

ICU Management

New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery

2017 27 Feb

Masimo (NASDAQ: MASI) has announced the findings of a recent study conducted on low-risk patients undergoing colorectal surgery, in which researchers assessed the utility of noninvasive and continuous Masimo PVi® (Pleth Variability Index) monitoring to guide fluid management, as compared to esophageal Doppler, an invasive method. The researchers found... Read more

ICU Management

Masimo Announces Recent Study Monitoring Methemoglobin Levels

2017 26 Feb

Masimo (NASDAQ: MASI) has announced the findings of a recent study conducted on children admitted to a Ugandan hospital with fever and malaria, in which Masimo’s noninvasive measurement SpMet® was used to monitor methemoglobin (MetHb) levels. One group of children with severe malaria was selected to receive inhaled nitric oxide (iNO) treatment as an... Read more

ICU Management

Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring Platform

2017 02 Feb

Masimo (NASDAQ: MASI) announced today the limited market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity platform. EWS aggregates information from multiple vital signs and clinical observations to generate a score that represents the potential degree of patient deterioration.Root, which works in conjunction with... Read more

ICU Management

Masimo Announces FDA 510(k) Clearance for TFA-1TM Single-Patient-Use Forehead Senso

2016 19 Dec

Masimo (NASDAQ:MASI) announced today FDA 510(k) clearance for the TFA-1™ Single-Patient-Use Adhesive Forehead Sensor. This single-patient-use sensor allows clinicians to monitor patients using Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry from an alternative monitoring site, the forehead, rather than a finger.Masimo TFA-1 Single-Patient-Use... Read more

ICU Management

Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device

2016 13 Nov

Masimo (NASDAQ: MASI) has announced, in advance of World Pneumonia Day tomorrow, that it has received a grant of $4.95 million from the Bill & Melinda Gates Foundation (BMGF). The grant will support Masimo’s efforts to develop a low-cost pulse oximeter for use in pneumonia screening in several low-resource areas outside the U.S. While still in development,... Read more

ICU Management

Philips & Masimo Sign Multi-Year Agreement in Patient Monitoring & Select Therapy Solutions

2016 07 Nov

Multi-year business partnership combines Masimo’s expertise in non-invasive sensor and signal processing technologies and Philips’ expertise in integrated patient monitoring and therapy solutionsBusiness partnership involves technology integration and marketing and sales cooperation in North America and certain markets in Asia and EuropeAgreement ends... Read more

ICU Management

Adam Mikkelson of Camber Capital Management Joins Masimo’s Board of Directors

2016 28 Oct

Masimo (NASDAQ: MASI), a global innovator of noninvasive patient monitoring technologies, announced today that Adam Mikkelson, Partner at Camber Capital Management, LLC, has been elected to Masimo’s Board of Directors.Mr. Mikkelson has been with Camber Capital Management, a healthcare-focused investment fund, since 2007. He has almost 15 years of experience... Read more